Alpha Cognition Inc
ACOG
Rank in Stocks
#16943
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Share Price
$8.62
Last synced: 2026-11-11
Market Cap
$187.69M
Change (1 day)
-1.26%
Change (1 year)
40.62%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Alpha Cognition Inc (ACOG)
Category
Healthcare
Operating Margin for Alpha Cognition Inc (ACOG)
Operating Margin as of November 2026 TTM: -190.55%
According to Alpha Cognition Inc's latest financial reports, its current operating margin (TTM) is -190.55%. At the end of 2025 the company had an operating margin of -221.72%.
Operating Margin history for Alpha Cognition Inc from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -190.55% | -14.06% |
| 2025 | -221.72% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -100.20% |
US
|
|
| -149.01% | -99.22% |
US
|
|
| 25.57% | -100.13% |
AU
|
|
| 31.23% | -100.16% |
BE
|
|
| 29.35% | -100.15% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Alpha Cognition Inc's operating margin
What is Alpha Cognition Inc's operating margin?
Alpha Cognition Inc's operating margin is -190.55%, as of Nov 2026.
What was Alpha Cognition Inc's operating margin in 2025?
In 2025, Alpha Cognition Inc's operating margin was -221.72%, compared with 0.00% in 2024.
How has Alpha Cognition Inc's operating margin changed since 2020?
From 2020 to 2025, Alpha Cognition Inc's operating margin was highest in 2024 (0.00%) and lowest in 2025 (-221.72%).
How does Alpha Cognition Inc's operating margin compare with similar companies?
Alpha Cognition Inc's operating margin (-190.55%) is lower than that of all 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.